Cargando…
The Antihelminthic Niclosamide Inhibits Cancer Stemness, Extracellular Matrix Remodeling, and Metastasis through Dysregulation of the Nuclear β-catenin/c-Myc axis in OSCC
Niclosamide is an oral chlorinated salicylanilide antihelminthic agent with potential anticancer activity suggested in several cancer types, however, its anticancer action and likely molecular mechanism in malignant oral cells remain unclear. In the present study, we demonstrated that ALDH+ human or...
Autores principales: | Wang, Lin-Hong, Xu, Mei, Fu, Luo-Qin, Chen, Xiao-Yi, Yang, Fan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109047/ https://www.ncbi.nlm.nih.gov/pubmed/30143678 http://dx.doi.org/10.1038/s41598-018-30692-3 |
Ejemplares similares
-
Niclosamide: Beyond an antihelminthic drug
por: Chen, Wei, et al.
Publicado: (2018) -
Antihelminthic niclosamide modulates dendritic cells activation and function
por: Wu, Chieh-Shan, et al.
Publicado: (2014) -
Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer
por: Lin, Chi-Kang, et al.
Publicado: (2016) -
The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo
por: Zhou, Jingfeng, et al.
Publicado: (2017) -
The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum
por: Zhou, Jingfeng, et al.
Publicado: (2020)